Biogen vs Hey Telo

Side-by-side comparison of AI visibility scores, market position, and capabilities

Biogen leads in AI visibility (91 vs 35)

Biogen

LeaderHealthcare Tech

Enterprise

Cambridge MA neuroscience biopharma (NASDAQ: BIIB) at $9.7B 2024 revenue; LEQEMBI $87M Q4 (Alzheimer's first-in-class amyloid therapy), SKYCLARYS $102M Q4 (Friedreich's ataxia), MS franchise declining vs. Eli Lilly donanemab.

AI VisibilityBeta
Overall Score
A91
Category Rank
#129 of 290
AI Consensus
84%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
93
Gemini
96

About

Biogen Inc. is a Cambridge, Massachusetts-based neuroscience biopharmaceutical company — publicly traded on NASDAQ (NASDAQ: BIIB) as an S&P 500 Health Care component — researching, developing, and commercializing therapies for neurological, neurodegenerative, and neurodevelopmental diseases including Alzheimer's disease, multiple sclerosis, spinal muscular atrophy, and rare neurological conditions through approximately 7,400 employees worldwide. In fiscal year 2024, Biogen reported total revenue of $9.7 billion (-2% year-over-year) and GAAP diluted EPS of $11.18 (+40%), reflecting significant cost-cutting that improved profitability despite modest revenue decline. Revenue decline was driven by continued erosion in the core multiple sclerosis franchise (TECFIDERA, AVONEX, TYSABRI facing generic and biosimilar competition) while new product revenue grew: LEQEMBI (lecanemab, Alzheimer's disease, partnered with Eisai) generated approximately $87 million in Q4 2024 global sales — reflecting the slow but building commercial trajectory of the first drug to slow Alzheimer's cognitive decline — and SKYCLARYS (omaveloxolone, Friedreich's ataxia) generated $102 million in Q4, nearly double the year-earlier period. CEO Christopher Viehbacher, who joined in 2022 from Genentech's parent Roche, has led a strategic restructuring that includes cost reduction, pipeline refocus on high-probability neurology programs, and the LEQEMBI commercial execution through a partnership model with Eisai.

Full profile

Hey Telo

EmergingHome Services

General

German craftsman AI voice agent answering calls and scheduling 24/7 for 1M+ Handwerk businesses; YC-backed targeting phone automation for HVAC, plumbing, and electrical trades in Germany.

AI VisibilityBeta
Overall Score
D35
Category Rank
#608 of 1167
AI Consensus
73%
Trend
stable
Per Platform
ChatGPT
30
Perplexity
27
Gemini
30

About

Hey Telo is a Berlin-based AI voice agent company building phone-answering and administrative automation specifically for Germany's 1 million+ independent craftsman businesses (Handwerksbetriebe) — HVAC technicians, plumbers, electricians, carpenters, and other skilled trades — who lose significant revenue daily to unanswered calls and administrative burden. A Y Combinator-backed startup, Hey Telo provides voice AI agents that answer calls professionally 24/7, schedule appointments, and provide quotes while the craftsman is on-site working.

Full profile

AI Visibility Head-to-Head

91
Overall Score
35
#129
Category Rank
#608
84
AI Consensus
73
stable
Trend
stable
99
ChatGPT
30
93
Perplexity
27
96
Gemini
30
99
Claude
32
95
Grok
39

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.